{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:08:56Z","timestamp":1789189736468,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pcad.2026.06.001","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:43:55Z","timestamp":1781624635000},"page":"89-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block"],"prefix":"10.1016","volume":"96","author":[{"given":"Thomas","family":"Van Overmeiren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Gonzalez","family":"de Alaiza Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"De Pooter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Donal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Timmermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pcad.2026.06.001_bb0005","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","article-title":"Diagnosis and evaluation of hypertrophic\u00a0cardiomyopathy","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2026.06.001_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"issue":"10253","key":"10.1016\/j.pcad.2026.06.001_bb0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pcad.2026.06.001_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jacc.2022.04.048","article-title":"Myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy","volume":"80","author":"Desai","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.06.001_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pcad.2024.02.001","article-title":"Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: Observations from a tertiary care center","volume":"86","author":"Desai","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.pcad.2026.06.001_bb0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10840-018-0407-2","article-title":"Left bundle branch block-induced left ventricular remodeling and its potential for reverse remodeling","volume":"52","author":"Sze","year":"2018","journal-title":"J Interv Card Electrophysiol"},{"issue":"3","key":"10.1016\/j.pcad.2026.06.001_bb0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mhj.2002.121264","article-title":"Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure","volume":"143","author":"Baldasseroni","year":"2002","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.pcad.2026.06.001_bb0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tcm.2018.10.012","article-title":"Mechanism of harm from left bundle branch block","volume":"29","author":"Smiseth","year":"2019","journal-title":"Trends Cardiovasc Med"},{"issue":"25","key":"10.1016\/j.pcad.2026.06.001_bb0045","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.jacc.2021.09.1381","article-title":"Effect of mavacamten on echocardiographic features in symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Hegde","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.06.001_bb0050","doi-asserted-by":"crossref","unstructured":"Massera D, Adlestein E, Li YI, et al. Predictors of left ventricular systolic dysfunction during treatment with mavacamten for obstructive hypertrophic cardiomyopathy. J Card Fail Intersect doi:https:\/\/doi.org\/10.1016\/j.yjcafi.2025.12.008.","DOI":"10.1016\/j.yjcafi.2025.12.008"},{"issue":"17","key":"10.1016\/j.pcad.2026.06.001_bb0055","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.033767","article-title":"Mavacamten for obstructive hypertrophic cardiomyopathy: rationale for clinically guided dose titration to optimize individual response","volume":"13","author":"Owens","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2026.06.001_bb0060","unstructured":"Camzyos: EPAR - Medicine overview. European Medicines Agency. Updated 23\/10\/2025. Accessed 24\/07\/2023, 2023. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/camzyos."},{"issue":"29","key":"10.1016\/j.pcad.2026.06.001_bb0065","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.pcad.2026.06.001_bb0070","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.amjcard.2010.11.010","article-title":"Defining left bundle branch block in the era of cardiac resynchronization therapy","volume":"107","author":"Strauss","year":"2011","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.pcad.2026.06.001_bb0080","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014296","article-title":"Clinical and experimental evidence for a strain-based classification of left bundle branch block-induced cardiac remodeling","volume":"15","author":"Calle","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.pcad.2026.06.001_bb0085","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jcmg.2021.02.019","article-title":"A strain-based staging classification of left bundle branch block-induced cardiac remodeling","volume":"14","author":"Calle","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.pcad.2026.06.001_bb0090","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2019.05.053","article-title":"Conduction abnormalities and long-term mortality following septal myectomy in patients with obstructive hypertrophic cardiomyopathy","volume":"74","author":"Cui","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2026.06.001_bb0095","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/ehjci\/jeaf162","article-title":"Strain-based staging as a unifying concept in cardiac resynchronization therapy","volume":"26","author":"Duchenne","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2026.06.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.echo.2025.12.016","article-title":"\u201cDivide et impera\u201d in cardiac resynchronization therapy?","author":"Van Overmeiren","year":"2026","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"10.1016\/j.pcad.2026.06.001_bb0105","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0735-1097(99)00068-6","article-title":"Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging","volume":"33","author":"Prinzen","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2026.06.001_bb0110","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/ehjci\/jew019","article-title":"Wasted septal work in left ventricular dyssynchrony: a novel principle to predict response to cardiac resynchronization therapy","volume":"17","author":"Vecera","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.pcad.2026.06.001_bb0115","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2005.04.062","article-title":"Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients","volume":"46","author":"Biagini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.06.001_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacasi.2026.04.002","article-title":"Mavacamten in hypertrophic cardiomyopathy: getting safety right when the buffer is small","author":"Zheng","year":"2026","journal-title":"JACC Asia"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062026000629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062026000629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:39:27Z","timestamp":1789187967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062026000629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":23,"alternative-id":["S0033062026000629"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2026.06.001","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2026.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}